85MO Cabozantinib as maintenance therapy in high grade uterine sarcoma after stabilization or response to doxorubicin +/- ifosfamide regimen: Results from EORTC 62113-55115-STBSG-GCG (NCT01979393), randomized double-blind phase II study

Ray-Coquard, I.L., Hatcher, H., Herraez, A.C. et al. (17 more authors) (2026) 85MO Cabozantinib as maintenance therapy in high grade uterine sarcoma after stabilization or response to doxorubicin +/- ifosfamide regimen: Results from EORTC 62113-55115-STBSG-GCG (NCT01979393), randomized double-blind phase II study. In: ESMO Rare Cancers. ESMO Sarcoma and Rare Cancers Congress 2026, 12-14 Mar 2026, Lugano, Switzerland. Vol. 5 (Supplement). Elsevier. Article no: 100291, pp. 4-5. ISSN: 3050-4619.

Metadata

Item Type: Conference abstract
Authors/Creators:
  • Ray-Coquard, I.L.
  • Hatcher, H.
  • Herraez, A.C.
  • Jones, R.
  • Casali, P.G.
  • Tromp, J.
  • Pratap, S.
  • Seddon, B.
  • Bompas, E.
  • Hervieu, A.
  • Morales, C.M.V.
  • Stark, D. ORCID logo https://orcid.org/0000-0002-6172-733X
  • Di Gioia, D.
  • Huizing, M.
  • Hermes, B.
  • Anand, A.
  • Oppong, F.
  • Coens, C.
  • Marreaud, S.
  • Reed, N.
Dates:
  • Published: 9 March 2026
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Date Deposited: 08 Jun 2026 13:31
Last Modified: 08 Jun 2026 13:31
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.esmorc.2026.100291
Open Archives Initiative ID (OAI ID):

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)